NUS: financial statements from SEC — TradeAlmanac

NUS

Nu Skin Enterprises, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	321m	364m	386m	364m	430m	439m
Cost of revenue	106m	107m	120m	118m	129m	132m
Gross profit	214m	257m	266m	247m	301m	307m
Selling, general and administrative	99m	105m	107m	113m	116m	118m
Operating expenses	210m	235m	235m	257m	283m	433m
Operating income	4m	22m	31m	−10m	18m	−126m
Interest expense	—	—	—	—	7m	7m
Pre-tax income	3m	16m	27m	135m	13m	−132m
Income tax	763,000	−1m	6m	27m	5m	−13m
Net income	2m	17m	21m	108m	8m	−118m
Earnings per share	0.04	0.35	0.43	2.16	0.17	−2.38
Earnings per share, diluted	0.04	0.34	0.43	2.14	0.17	−2.38
Weighted average shares	48m	49m	49m	50m	50m	50m
Weighted average shares, diluted	49m	50m	49m	50m	50m	50m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	199m	239m	252m	264m	204m	187m	228m	224m
Short-term investments	2m	1m

Cash flow

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	−4m	—	—	389,000	—	—
Depreciation and amortisation	12m	12m	13m	14m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)